Skip to Content

Achaogen Inc

Rating as of

Company Profile

Business Description

Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is generated from government contracts for research and development in the United States.

1 Tower Place, Suite 400
South San Francisco, CA, 94080
T +1 650 800-3636
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Dec 31, 2018
Fiscal Year End Dec 31, 2019
Stock Type Distressed
Employees 42